SIRT1 Gene

SIRT1 Gene

Introduction

Pathway Diagram

```mermaid
flowchart TD
SIRT1["SIRT1<br/>Sirtuin 1<br/>NAD+ dependent<br/>deacetylase"]

AUTOPHAGY["Autophagy<br/>Pathway"]
OXIDATIVE_STRESS["Oxidative<br/>Stress"]
INFLAMMATION["Neuroinflammation"]
AGING["Cellular<br/>Aging"]

ALZHEIMER["Alzheimer's<br/>Disease"]
PARKINSON["Parkinson's<br/>Disease"]
ALS["Amyotrophic<br/>Lateral Sclerosis"]
MS["Multiple<br/>Sclerosis"]

NEUROPROTECTION["Neuroprotection"]
MITOCHONDRIAL["Mitochondrial<br/>Function"]
PROTEIN_AGGREGATION["Protein<br/>Aggregation"]
NEURONAL_SURVIVAL["Neuronal<br/>Survival"]

DNA_REPAIR["DNA Repair<br/>Mechanisms"]
METABOLIC_REGULATION["Metabolic<br/>Regulation"]

SIRT1 -->|"promotes"| AUTOPHAGY
SIRT1 -->|"inhibits"| OXIDATIVE_STRESS
SIRT1 -->|"protects against"| INFLAMMATION
SIRT1 -->|"regulates"| AGING
SIRT1 -->|"enhances"| MITOCHONDRIAL
SIRT1 -->|"activates"| DNA_REPAIR
SIRT1 -->|"controls"| METABOLIC_REGULATION

AUTOPHAGY -->|"reduces"| PROTEIN_AGGREGATION
AUTOPHAGY -->|"promotes"| NEURONAL_SURVIVAL

OXIDATIVE_STRESS -->|"contributes to"| ALZHEIMER
OXIDATIVE_STRESS -->|"contributes to"| PARKINSON
PROTEIN_AGGREGATION -->|"leads to"| ALZHEIMER
PROTEIN_AGGREGATION -->|"leads to"| ALS

INFLAMMATION -->|"drives"| MS
INFLAMMATION -->|"exacerbates"| PARKINSON

MITOCHONDRIAL -->|"supports"| NEUROPROTECTION
DNA_REPAIR -->|"maintains"| NEURONAL_SURVIVAL
METABOLIC_REGULATION -->|"influences"| AGING

SIRT1 Gene

Introduction

Pathway Diagram

Sirt1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene"> [@haigis2006]
<div class="infobox-header">SIRT1</div> [@qin]
<div class="infobox-content"> [@min2018] Full Name: Sirtuin 1<br> [@jesus2021] Chromosomal Location: 10q21.3<br> NCBI Gene ID: 23411<br> OMIM: 604479<br> Ensembl ID: ENSG00000096717<br> UniProt: Q96EB6<br> Associated Diseases: Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Metabolic Syndrome
</div>
</div>

Overview

SIRT1 (Sirtuin 1) is a NAD+-dependent class III histone deacetylase that catalyzes the removal of acetyl groups from lysine residues on histones and various regulatory proteins. As a master regulator of cellular stress responses, metabolism, and aging, SIRT1 has emerged as a critical protective factor in neurodegenerative diseases. SIRT1 activation promotes longevity and neuroprotection through multiple downstream targets including PGC-1α, FOXO, p53, and [NF-κB](/entities/nf-kb).

Function

SIRT1 uses NAD+ as a cofactor, linking its activity to cellular energy status and metabolic health. The enzyme deacetylates both histones (H3K9, H3K14, H4K16) and non-histone proteins, thereby regulating gene expression and protein function.

Key functions include:

• Chromatin Regulation: Deacetylates histones to promote heterochromatin formation and silence repetitive elements
• Metabolic Regulation: Activates PGC-1α for mitochondrial biogenesis
• Stress Response: Deacetylates FOXO transcription factors to enhance antioxidant gene expression
• Inflammation: Inhibits NF-κB signaling through deacetylation
• Protein Quality Control: Promotes [autophagy](/entities/autophagy) and proteasomal degradation
• DNA Repair: Facilitates DNA damage repair through histone deacetylation

Disease Associations

Alzheimer's Disease

• Deacetylates [tau](/proteins/tau) and reduces its aggregation
• Activates alpha-secretase (ADAM10) to promote non-amyloidogenic [APP](/entities/app-protein) processing
• Reduces [Aβ](/proteins/amyloid-beta)-induced neurotoxicity
• Anti-inflammatory effects through NF-κB inhibition
• Promotes mitochondrial function and reduces oxidative stress

Parkinson's Disease

• Mitochondrial biogenesis via PGC-1α activation
• Reduction of [alpha-synuclein](/mechanisms/alpha-synuclein) aggregation
• Protection against 6-OHDA and MPTP toxicity
• Enhancement of autophagy to clear damaged proteins
• Anti-apoptotic effects through FOXO activation

Sirtuin Pathway Dysfunction in PD

The [Sirtuin Pathway Dysfunction Hypothesis in Parkinson's Disease](/hypotheses/sirtuin-pathway-dysfunction-parkinsons) proposes that SIRT1 dysfunction is a primary driver of dopaminergic neurodegeneration. Key connections include:

Clinical Evidence for SIRT1 in PD

| Finding | Study | PMID |
|---------|-------|------|
| SIRT1 activity reduced in PD patient-derived neurons | Tyrrell et al. | [30659479](https://pubmed.ncbi.nlm.nih.gov/30659479/) |
| SIRT1 rs7895833 A allele increases PD risk | Liu et al. | [29550616](https://pubmed.ncbi.nlm.nih.gov/29550616/) |
| SRT2104 (SIRT1 activator) protects in MPTP model | -- | -- |

SIRT1 in the NADAPT Study

The [NADAPT Study (NCT06162013)](/clinical-trials/nadapt-study-nad-replenishment-parkinsonism-nct06162013) evaluates NAD+ precursor supplementation, which indirectly increases SIRT1 activity by providing more substrate (NAD+). This provides a therapeutic approach to address SIRT1 dysfunction in PD.

See the [Sirtuin Pathway Dysfunction Validation Experiment](/experiments/sirtuin-pathway-dysfunction-parkinsons) for detailed study design.

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin-protein) protein causes SIRT1 dysregulation
• SIRT1 activation reduces mHTT toxicity in models
• PGC-1α activation compensates for mitochondrial dysfunction
• Deacetylates [huntingtin](/genes/htt) to promote clearance
• Resveratrol and other SIRT1 activators show preclinical promise

Expression

SIRT1 is widely expressed in the brain with high levels in:

• [Hippocampus](/brain-regions/hippocampus) (CA1, dentate gyrus)
• Cerebral [cortex](/brain-regions/cortex) (layers II-III, V)
• [Hypothalamus](/brain-regions/hypothalamus)
• Cerebellum (Purkinje cells)
• Substantia nigra pars compacta

Key Publications

Therapeutic Targeting

| Agent | Mechanism | Development Stage | Notes |
|-------|-----------|-------------------|-------|
| Resveratrol | SIRT1 activator | Phase II/III | Natural compound, limited bioavailability |
| SRT1720 | SIRT1 selective activator | Preclinical | 1000x potency vs resveratrol |
| SRT2104 | SIRT1 selective activator | Phase I | Good brain penetration |
| NAD+ precursors | SIRT1 substrate | Phase II | NR, NMN increase SIRT1 activity |
| Piceatannol | SIRT1 activator | Preclinical | Analog of resveratrol |

Cross-Links

• [SIRT1 Protein](/proteins/sirt1-protein)
• [PARP1 Gene](/proteins/parp1-protein)
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons)
• [Sirtuin Pathway Dysfunction Hypothesis in PD](/hypotheses/sirtuin-pathway-dysfunction-parkinsons)
• [Sirtuin Pathway Dysfunction Validation Experiment](/experiments/sirtuin-pathway-dysfunction-parkinsons)

Background

The study of Sirt1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein](/mechanisms/alpha-synuclein)

Allen Brain Atlas Resources

• [Allen Human Brain Atlas*: [SIRT1 gene expression](https://human.brain-map.org/microarray/search/show?search_term=SIRT1)](/datasets/allen-human-brain-atlas)
• [Allen Mouse Brain Atlas*: [SIRT1 expression](https://mouse.brain-map.org/search/index.html?query=SIRT1)](/projects/brain-atlas)
• [Allen Cell Type Atlas*: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)](/cell-types/atlas)
• [BrainSpan Atlas*: [SIRT1 developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=SIRT1)](/datasets/brainspan-atlas)

References

[@imai2000]: Imai S et al. (2000). Sir2: a NAD-dependent histone deacetylase that links metabolism to longevity. Cell. PMID: 10802658(https://pubmed.ncbi.nlm.nih.gov/10802658/)
[@haigis2006]: Haigis MC et al. (2006). SIRT1 in brain aging and Alzheimer's disease. Aging Cell. PMID: 16905760(https://pubmed.ncbi.nlm.nih.gov/16905760/)
[@qin]: Qin W et al. (2002006). SIRT1 promotes the central nervous system. J Biol Chem. PMID: 16469845(https://pubmed.ncbi.nlm.nih.gov/16469845/)
[@min2018]: Min SW et al. (2018). SIRT1 deacetylates tau and reduces neurodegeneration in models of Alzheimer's disease. Nat Rev Neurol. PMID: 29559788(https://pubmed.ncbi.nlm.nih.gov/29559788/)
[@jesus2021]: Jesus M et al. (2021). SIRT1 and neurodegenerative diseases: from molecular mechanisms to therapeutic interventions. Mol Neurobiol. PMID: 33788123(https://pubmed.ncbi.nlm.nih.gov/33788123/)

External Links

• [NCBI Gene: SIRT1](https://www.ncbi.nlm.nih.gov/gene/23411)
• [UniProt: Q96EB6](https://www.uniprot.org/uniprot/Q96EB6)
• [OMIM: 604479](https://www.omim.org/entry/604479)

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — <span style="color:#81c784;font-weight:600">0.62</span> · Target: SIRT1

Pathway Diagram

The following diagram shows the key molecular relationships involving SIRT1 Gene discovered through SciDEX knowledge graph analysis: